pDNR-SpCas9-Gem Citations (4)

Originally described in: A Cas9 Variant for Efficient Generation of Indel-Free Knockin or Gene-Corrected Human Pluripotent Stem Cells.
Howden SE, McColl B, Glaser A, Vadolas J, Petrou S, Little MH, Elefanty AG, Stanley EG Stem Cell Reports. 2016 Sep 13;7(3):508-17. doi: 10.1016/j.stemcr.2016.07.001. Epub 2016 Aug 4. PubMed Journal

---

Articles Citing pDNR-SpCas9-Gem

Articles
Simultaneous reprogramming and gene editing of human fibroblasts. Howden SE, Thomson JA, Little MH. Nat Protoc. 2018 May;13(5):875-898. doi: 10.1038/nprot.2018.007. Epub 2018 Apr 5. PubMed
Generation of a heterozygous COL1A1 (c.3969_3970insT) osteogenesis imperfecta mutation human iPSC line, MCRIi001-A-1, using CRISPR/Cas9 editing. Hosseini Far H, Patria YN, Motazedian A, Elefanty AG, Stanley EG, Lamande SR, Bateman JF. Stem Cell Res. 2019 May;37:101449. doi: 10.1016/j.scr.2019.101449. Epub 2019 Apr 23. PubMed
Generation and heterozygous repair of human iPSC lines from three individuals with cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS) carrying biallelic AAGGG expansions in RFC1. Davies KC, Bozaoglu K, Lockhart PJ. Stem Cell Res. 2023 Apr;68:103047. doi: 10.1016/j.scr.2023.103047. Epub 2023 Feb 14. PubMed
Generation of heterozygous (MCRIi030-A-1) and homozygous (MCRIi030-A-2) NR2F2/COUP-TFII knockout human iPSC lines. Ferreira LGA, Cabral-da-Silva MC, Pachernegg S, van den Bergen JA, Robevska G, Vlahos K, Howden SE, Ng ES, Dias-da-Silva MR, Sinclair AH, Ayers KL. Stem Cell Res. 2024 Apr;76:103374. doi: 10.1016/j.scr.2024.103374. Epub 2024 Mar 2. PubMed

If you have published an article using this material, please email us at to have your article added to this page.